Skip to content
Sign in

ELAN · NYSE

Elanco Animal Health (ELAN) Stock Price & Fundamentals

$615.56−0.49%−$3.04End-of-day price as of Oct 9, 2026

Elanco Animal Health (ELAN) closed at $615.56 on Oct 9, 2026, down 0.49% from the previous close of $618.60.

Share price, past year

1Y +18.61%

52-week range $496.49 – $618.60. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$615.56
Sep 30, 2026$607.14
Aug 31, 2026$596.87
Jul 31, 2026$583.17
Jun 30, 2026$560.64
May 29, 2026$566.43
Apr 30, 2026$586.94
Mar 31, 2026$553.32
Feb 27, 2026$521.94
Jan 30, 2026$526.64
Dec 31, 2025$524.04
Nov 28, 2025$568.45
Oct 31, 2025$547.67

Key statistics

Market cap
$307.50B
P/E (TTM)
—
EPS (TTM)
−$0.40
Revenue (TTM)
$5.02B
Net income (TTM)
−$199.00M
Shares outstanding
499.5M
Dividend yield
—
52-week range
$496.49 – $618.60

Elanco Animal Health's market cap is $307.50B, based on a share price of $615.56 and 499.5M shares outstanding as of Jun 30, 2026.

Financials

Elanco Animal Health reported revenue of $4.72B for fiscal 2025, up 6.22% from fiscal 2024.

Elanco Animal Health reported a net loss of $232.00M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Elanco Animal Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$4.72B+6.2%−$232.00M−4.9%−$0.47$284.00M
FY2024ended Dec 31, 2024$4.44B+0.5%$338.00M7.6%$0.68$394.00M
FY2023ended Dec 31, 2023$4.42B+0.1%−$1.23B−27.9%−$2.50$131.00M
FY2022ended Dec 31, 2022$4.41B−7.4%−$78.00M−1.8%−$0.16$281.00M
FY2021ended Dec 31, 2021$4.76B+45.6%−$483.00M−10.1%−$0.99$324.00M
FY2020ended Dec 31, 2020$3.27B+6.6%−$574.00M−17.5%−$1.30−$176.00M
FY2019ended Dec 31, 2019$3.07B+0.1%$68.00M2.2%$0.18$84.00M
FY2018ended Dec 31, 2018$3.07B+6.2%$86.50M2.8%$0.28$352.80M
FY2017ended Dec 31, 2017$2.89B−0.8%−$310.70M−10.8%−$1.06$75.20M
FY2016ended Dec 31, 2016$2.91B—−$47.90M−1.6%−$0.16$45.60M
Elanco Animal Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$1.37B$54.00M$0.11
Q1 FY2026ended Mar 31, 2026$1.37B$57.00M$0.11
Q4 FY2025ended Dec 31, 2025$1.14B−$276.00M−$0.55
Q3 FY2025ended Sep 30, 2025$1.14B−$34.00M−$0.07
Q2 FY2025ended Jun 30, 2025$1.24B$11.00M$0.02
Q1 FY2025ended Mar 31, 2025$1.19B$67.00M$0.13
Q4 FY2024ended Dec 31, 2024$1.02B−$8.00M−$0.01
Q3 FY2024ended Sep 30, 2024$1.03B$364.00M$0.73

Company profile

Name
Elanco Animal Health Inc
Ticker
ELAN
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
450 Elanco Circle, Indianapolis, IN 46221
Fiscal year ends
December
SEC CIK
0001739104

Recent SEC filings

Frequently asked questions

What is Elanco Animal Health's stock price?

Elanco Animal Health (ELAN) closed at $615.56 on Oct 9, 2026, down 0.49% from the previous close of $618.60.

What is Elanco Animal Health's market cap?

Elanco Animal Health's market cap is $307.50B, based on a share price of $615.56 and 499.5M shares outstanding as of Jun 30, 2026.

How much revenue does Elanco Animal Health make?

Elanco Animal Health reported revenue of $4.72B for fiscal 2025, up 6.22% from fiscal 2024.

Does Elanco Animal Health pay a dividend?

Elanco Animal Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Elanco Animal Health Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures